Boston Healthcare To Expand Consultancy Into Asia

Boston Healthcare is expanding into Asia with the formation of a strategic advisory practice in Hong Kong.

AsianScientist (Nov. 29, 2012) – Boston Healthcare announced this week the expansion of its consulting services into Asia with the formation of a strategic advisory practice in Hong Kong, China.

The Asia practice will be headed by Ms. Betty Su, who will become Managing Director for Boston Healthcare Associates International Hong Kong Limited.

Su specializes in market access and regulatory strategy in China, advising drug, device, and diagnostics companies on commercialization and business development opportunities. Prior to her consulting role, she held several positions at AstraZeneca in China in marketing, government affairs, and corporate communications.

“Hong Kong and China are rapidly growing pharmaceutical and medical device markets, as well as emerging leaders in health care technology innovation,” said Joseph V. Ferrara, President of Boston Healthcare.

“The expansion of our practice in Asia provides our clients with strong support in reimbursement and market access in this vital region,” he added.

Boston Healthcare has offices in Boston, Washington, D.C., Berlin, and Hong Kong. It supports the reimbursement and market access needs of pharmaceutical, medical device, and diagnostics companies worldwide.

——

Source: Boston Healthcare.
Disclaimer: This article does not necessarily reflect the views of AsianScientist or its staff.

Asian Scientist Magazine is an award-winning science and technology magazine that highlights R&D news stories from Asia to a global audience. The magazine is published by Singapore-headquartered Wildtype Media Group.

Related Stories from Asian Scientist